Emerald Health Therapeutics, Inc. announced earnings results for the third quarter ended September 30, 2020. For the third quarter, the company announced total revenue was CAD 3.373 million compared to CAD 9.298 million a year ago. Operating income was CAD 9.879 million compared to CAD 14.695 million a year ago. Net loss was CAD 11.491 million compared to CAD 17.253 million a year ago. Basic loss per share from continuing operations was CAD 0.06 compared to CAD 0.12 a year ago. For the nine months, total revenue was CAD 8.743 million compared to CAD 16.047 million a year ago. Operating income was CAD 19.006 million compared to CAD 38.392 million a year ago. Net loss was CAD 35.087 million compared to CAD 20.971 million a year ago. Basic loss per share from continuing operations was CAD 0.19 compared to CAD 0.15 a year ago.